3 results
Approved WMOCompleted
To investigate whether ticagrelor increases adenosine receptor stimulation in humans in vivo by ENT inhibition.
Approved WMOCompleted
The overall safety objective of this study is to assess the safety and tolerability of long-term therapy with ticagrelor compared to placebo in patients with T2DM at high risk of CV events, with or without background low-dose ASA therapy. Bleeding…
Approved WMOCompleted
To assess the safety, efficacy and net clinical benefit of clopidogrel versus the new antiplatelet drugs i.e. ticagrelor and prasugrel in patients older than 70 years.